Novavax Inc (NVAX)

$6.26 -0.15 (-2.34%)
Market Cap 1.04B
Revenue (ttm) 682.16M
Net Income (ttm) -187.50M
EPS (ttm) N/A
PE Ratio 2.42
Forward PE 3.16
Profit Margin -27.49%
Debt to Equity Ratio 0.00
Volume 2,346,008
Avg Vol 9,724,972
Day's Range N/A - N/A
Shares Out 161.97M
Stochastic %K 10%
Beta 2.80
Analysts Sell
Price Target $14.12

Company Profile

Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax...

Industry: Biotechnology
Sector: Healthcare
Phone: 240 268 2000
Address:
700 Quince Orchard Road, Gaithersburg, United States
LouAlwaysKnew
LouAlwaysKnew Jun. 23 at 6:03 PM
$NVAX Pigs in power just milking the premiums while RFK takes orders from the dark elites and SEC is looking the other way. Sad this is the only real vaccine but it's being abused by JPMorgan and execs. The reverse stock split 6 months before the plandemic was a set up to make manipulation even easier. They should all be in jail.
0 · Reply
marketlimit
marketlimit Jun. 23 at 5:59 PM
$NVAX $4 next week
0 · Reply
marketlimit
marketlimit Jun. 23 at 5:59 PM
$NVAX L M A O !!! $5 this week
0 · Reply
OneDollarBob
OneDollarBob Jun. 23 at 5:57 PM
$NVAX It’s getting in to that range where JJ likes to sell shares.
0 · Reply
pepi0815
pepi0815 Jun. 23 at 5:51 PM
$NVAX hold an have fun. Time will come.
0 · Reply
SanofiNovavax
SanofiNovavax Jun. 23 at 5:43 PM
$NVAX does anyone know how to get free shares? it would greatly help to average down 🤣 i mean might as well go down to $1 so we can all just average down before it goes up 100% to $2 🤣 our investment is a joke. lets just laugh about how much we got screwed up by management Stan and JJ.
1 · Reply
CapitalGrowth
CapitalGrowth Jun. 23 at 5:22 PM
$NVAX JJ seems to bring up investor value creation at every earnings call yet he never shows any signs of defending or supporting the unfairly targeted/manipulated stock price. I give him credit for turning the company around, but Why the total disregard for the share holders?!
0 · Reply
Find_the_Cure
Find_the_Cure Jun. 23 at 5:19 PM
$NVAX )100 bound when mRNA halted
0 · Reply
CaptQuint
CaptQuint Jun. 23 at 5:12 PM
$NVAX doubled up, avg near even. Bulls time to ride back.
0 · Reply
vsholding
vsholding Jun. 23 at 5:11 PM
$NVAX As it seams, Citi's loyalty wasted their ammunition, and WSJ's followers and investors are getting involved.
0 · Reply
Latest News on NVAX
Novavax, Inc. (NVAX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

Jun 11, 2025, 8:59 PM EDT - 11 days ago

Novavax, Inc. (NVAX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study

Jun 11, 2025, 7:11 AM EDT - 12 days ago

Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study

Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

Jun 11, 2025, 7:00 AM EDT - 12 days ago

Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

Vaccine actions and policy positions under US Health Secretary Kennedy

Jun 10, 2025, 10:45 AM EDT - 13 days ago

Vaccine actions and policy positions under US Health Secretary Kennedy

BNTX MRNA PFE

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

Jun 10, 2025, 9:30 AM EDT - 13 days ago

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

BNTX MRNA PFE

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

Jun 10, 2025, 8:18 AM EDT - 13 days ago

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

BNTX MRNA PFE SNY

Novavax to Participate in Upcoming Investor Conferences

May 29, 2025, 8:00 AM EDT - 25 days ago

Novavax to Participate in Upcoming Investor Conferences

Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli

May 21, 2025, 8:15 AM EDT - 4 weeks ago

Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

May 20, 2025, 4:34 PM EDT - 4 weeks ago

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

May 19, 2025, 12:15 PM EDT - 5 weeks ago

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

AZO TSLA

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

May 19, 2025, 9:27 AM EDT - 5 weeks ago

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

May 19, 2025, 7:16 AM EDT - 5 weeks ago

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine

May 19, 2025, 7:00 AM EDT - 5 weeks ago

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine

FDA approves Novavax COVID vaccine with new conditions

May 17, 2025, 10:26 PM EDT - 5 weeks ago

FDA approves Novavax COVID vaccine with new conditions

Novavax, Inc. (NVAX) Presents at BofA Securities 2025 Health Care Conference (Transcript)

May 14, 2025, 10:46 PM EDT - 5 weeks ago

Novavax, Inc. (NVAX) Presents at BofA Securities 2025 Health Care Conference (Transcript)

Novavax: Initiating Hold Rating After Strong, But Misunderstood Q1 2025 Earnings Beat

May 12, 2025, 12:45 PM EDT - 6 weeks ago

Novavax: Initiating Hold Rating After Strong, But Misunderstood Q1 2025 Earnings Beat

COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why

May 8, 2025, 1:31 PM EDT - 6 weeks ago

COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why

Novavax, Inc. (NVAX) Q1 2025 Earnings Call Transcript

May 8, 2025, 11:48 AM EDT - 6 weeks ago

Novavax, Inc. (NVAX) Q1 2025 Earnings Call Transcript

Why This Shrinking Covid-19 Vaccine Stock Jumped 30%

May 8, 2025, 11:12 AM EDT - 6 weeks ago

Why This Shrinking Covid-19 Vaccine Stock Jumped 30%

Novavax swings to profit on lower expenses related to COVID shots

May 8, 2025, 8:06 AM EDT - 6 weeks ago

Novavax swings to profit on lower expenses related to COVID shots

Novavax Reports First Quarter 2025 Financial Results and Operational Highlights

May 8, 2025, 8:00 AM EDT - 6 weeks ago

Novavax Reports First Quarter 2025 Financial Results and Operational Highlights

New vaccine chief rocks pharmaceutical stocks

May 7, 2025, 11:13 AM EDT - 6 weeks ago

New vaccine chief rocks pharmaceutical stocks

BNTX MRNA PFE GSK IBB SRPT XBI

Novavax to Participate in BofA Securities 2025 Health Care Conference

May 7, 2025, 8:00 AM EDT - 6 weeks ago

Novavax to Participate in BofA Securities 2025 Health Care Conference

Novavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid® in Japan

May 5, 2025, 8:00 AM EDT - 7 weeks ago

Novavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid® in Japan

Novavax to Report First Quarter 2025 Financial Results on May 8, 2025

May 1, 2025, 8:00 AM EDT - 7 weeks ago

Novavax to Report First Quarter 2025 Financial Results on May 8, 2025

Novavax Appoints Charles Newton to Board of Directors

Apr 29, 2025, 8:00 AM EDT - 7 weeks ago

Novavax Appoints Charles Newton to Board of Directors

FDA asks Novavax to complete new clinical trial for delayed COVID-19 shot, WSJ reports

Apr 25, 2025, 3:35 PM EDT - 2 months ago

FDA asks Novavax to complete new clinical trial for delayed COVID-19 shot, WSJ reports

FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot

Apr 25, 2025, 3:20 PM EDT - 2 months ago

FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot

Insight: As FDA delays Novavax' COVID vaccine approval, patients fight back

Apr 24, 2025, 6:04 AM EDT - 2 months ago

Insight: As FDA delays Novavax' COVID vaccine approval, patients fight back

Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps

Apr 23, 2025, 5:00 PM EDT - 2 months ago

Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps

FDA asks Novavax for commitment on post-approval studies for COVID vaccine

Apr 23, 2025, 8:26 AM EDT - 2 months ago

FDA asks Novavax for commitment on post-approval studies for COVID vaccine

SHIELD-Utah Study Shows Novavax's COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA

Apr 15, 2025, 7:00 AM EDT - 2 months ago

SHIELD-Utah Study Shows Novavax's COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA

Novavax shares tumble after U.S. health secretary raises concerns over COVID shot's efficacy

Apr 10, 2025, 3:02 PM EDT - 2 months ago

Novavax shares tumble after U.S. health secretary raises concerns over COVID shot's efficacy

The FDA was moving to grant full approval for Novavax's Covid-19 vaccine. But it missed the April 1 deadline after the agency's vaccine chief was forced out.

Apr 2, 2025, 1:20 PM EDT - 2 months ago

The FDA was moving to grant full approval for Novavax's Covid-19 vaccine. But it missed the April 1 deadline after the agency's vaccine chief was forced out.

FDA misses deadline for decision on Novavax's COVID-19 vaccine, WSJ reports

Apr 2, 2025, 12:29 PM EDT - 2 months ago

FDA misses deadline for decision on Novavax's COVID-19 vaccine, WSJ reports

Vaccine stocks fall following FDA resignation

Mar 31, 2025, 6:21 PM EDT - 2 months ago

Vaccine stocks fall following FDA resignation

BNTX MRNA PFE PCVX PTCT XBI

Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views

Mar 31, 2025, 2:41 PM EDT - 2 months ago

Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views

BNTX MRNA PFE

Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul

Mar 31, 2025, 2:25 PM EDT - 2 months ago

Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul

BNTX SLDB SRPT TSHA XBI

Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.

Mar 31, 2025, 10:13 AM EDT - 3 months ago

Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.

BNTX MRNA PFE

Biotech stocks tumble on reports FDA's top vaccine regulator to leave

Mar 31, 2025, 7:25 AM EDT - 3 months ago

Biotech stocks tumble on reports FDA's top vaccine regulator to leave

BNTX MRNA PFE

Novavax, Inc. (NVAX) Leerink Partners 2025 Global Healthcare Conference (Transcript)

Mar 11, 2025, 7:48 PM EDT - 3 months ago

Novavax, Inc. (NVAX) Leerink Partners 2025 Global Healthcare Conference (Transcript)

Novavax Announces Changes to Board of Directors

Mar 11, 2025, 8:00 AM EDT - 3 months ago

Novavax Announces Changes to Board of Directors

Novavax, Inc. (NVAX) TD Cowen 45th Annual Health Care Conference (Transcript)

Mar 4, 2025, 1:34 PM EST - 3 months ago

Novavax, Inc. (NVAX) TD Cowen 45th Annual Health Care Conference (Transcript)

Novavax Q4 Earnings Review: Long-Term Downsizing Plan Suggests Sell Rating

Feb 28, 2025, 11:16 AM EST - 4 months ago

Novavax Q4 Earnings Review: Long-Term Downsizing Plan Suggests Sell Rating

Novavax to Participate in Upcoming March Investor Conferences

Feb 27, 2025, 4:05 PM EST - 4 months ago

Novavax to Participate in Upcoming March Investor Conferences

Novavax, Inc. (NVAX) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 11:42 AM EST - 4 months ago

Novavax, Inc. (NVAX) Q4 2024 Earnings Call Transcript

Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize Value

Feb 27, 2025, 11:24 AM EST - 4 months ago

Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize Value

Novavax's quarterly loss shrinks as it ramps down spending on COVID vaccines

Feb 27, 2025, 8:06 AM EST - 4 months ago

Novavax's quarterly loss shrinks as it ramps down spending on COVID vaccines

Novavax Stock Is Rising. Revenue Beat Estimates.

Feb 27, 2025, 8:05 AM EST - 4 months ago

Novavax Stock Is Rising. Revenue Beat Estimates.

Novavax Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Feb 27, 2025, 8:00 AM EST - 4 months ago

Novavax Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

LouAlwaysKnew
LouAlwaysKnew Jun. 23 at 6:03 PM
$NVAX Pigs in power just milking the premiums while RFK takes orders from the dark elites and SEC is looking the other way. Sad this is the only real vaccine but it's being abused by JPMorgan and execs. The reverse stock split 6 months before the plandemic was a set up to make manipulation even easier. They should all be in jail.
0 · Reply
marketlimit
marketlimit Jun. 23 at 5:59 PM
$NVAX $4 next week
0 · Reply
marketlimit
marketlimit Jun. 23 at 5:59 PM
$NVAX L M A O !!! $5 this week
0 · Reply
OneDollarBob
OneDollarBob Jun. 23 at 5:57 PM
$NVAX It’s getting in to that range where JJ likes to sell shares.
0 · Reply
pepi0815
pepi0815 Jun. 23 at 5:51 PM
$NVAX hold an have fun. Time will come.
0 · Reply
SanofiNovavax
SanofiNovavax Jun. 23 at 5:43 PM
$NVAX does anyone know how to get free shares? it would greatly help to average down 🤣 i mean might as well go down to $1 so we can all just average down before it goes up 100% to $2 🤣 our investment is a joke. lets just laugh about how much we got screwed up by management Stan and JJ.
1 · Reply
CapitalGrowth
CapitalGrowth Jun. 23 at 5:22 PM
$NVAX JJ seems to bring up investor value creation at every earnings call yet he never shows any signs of defending or supporting the unfairly targeted/manipulated stock price. I give him credit for turning the company around, but Why the total disregard for the share holders?!
0 · Reply
Find_the_Cure
Find_the_Cure Jun. 23 at 5:19 PM
$NVAX )100 bound when mRNA halted
0 · Reply
CaptQuint
CaptQuint Jun. 23 at 5:12 PM
$NVAX doubled up, avg near even. Bulls time to ride back.
0 · Reply
vsholding
vsholding Jun. 23 at 5:11 PM
$NVAX As it seams, Citi's loyalty wasted their ammunition, and WSJ's followers and investors are getting involved.
0 · Reply
Eesnimi
Eesnimi Jun. 23 at 5:06 PM
$NVAX Worst 1B+ cap stock to own on the planet for the last 4 years?
0 · Reply
PeterMarksMD
PeterMarksMD Jun. 23 at 5:05 PM
$NVAX Turd has got to turd.
0 · Reply
Jeffmids
Jeffmids Jun. 23 at 5:04 PM
$NVAX Novashite strikes again .
0 · Reply
Chelsea100
Chelsea100 Jun. 23 at 4:58 PM
$NVAX Massive attack. Some players clearly want to push the stock below $6. We just had the shareholders' meeting, and still no CiC partner announced. Our market cap is now $1 billion, with $700–800 million in cash.
1 · Reply
Trader00995
Trader00995 Jun. 23 at 4:38 PM
$NVAX Newton?
1 · Reply
RD008
RD008 Jun. 23 at 4:37 PM
$NVAX HOLD strong let us take it to $7 by end of today
1 · Reply
Find_the_Cure
Find_the_Cure Jun. 23 at 4:36 PM
$NVAX why why why JJ?!?!?
0 · Reply
kwinters71
kwinters71 Jun. 23 at 4:36 PM
$NVAX I have been a fan of JJ, haven't understood everything he has done, but he has done some good things, however, if he is not negotiating a deal right now for CIC/Flu with good upfront money, he needs to be replaced with someone that can get it done, a deal should have already been announced IMO
1 · Reply
SanofiNovavax
SanofiNovavax Jun. 23 at 4:35 PM
$NVAX about to go under $6
1 · Reply
WhosYourDaddy_
WhosYourDaddy_ Jun. 23 at 4:32 PM
$NVAX CITI OWNS THIS BITCH...
0 · Reply
mpatch23
mpatch23 Jun. 23 at 4:27 PM
$NVAX
0 · Reply
vsholding
vsholding Jun. 23 at 4:27 PM
$NVAX Citi must be wasting (investing) a lot of money to prove their "forecast."
0 · Reply